LONGEVA.

TB-500: reconstitution and reference parameters

tb-500 dosage

> Updated:

TB-500 (preset)

Calculate the TB-500 dose

The calculator is already set up for TB-500 — adjust the dose or diluent volume for your vial.

Open calculator

In short

TB-500 is a thymosin beta-4 fragment, reconstituted from lyophilized powder and given subcutaneously. There are no controlled human trials of the fragment, so the schedule below is compiled from community protocols: loading at 4–5 mg per week in two injections for 4–6 weeks, then maintenance at 2–2.5 mg once weekly and, if needed, every other week.

Human dosing

Period / conditionDoseEscalation
Loading (4–6 weeks)4–5 mg per week, split into 2 injectionsStarting phase
Maintenance (4–6 weeks)2–2.5 mg weeklyReduced after loading
Spaced maintenance2–2.5 mg every other weekMinimum in this schedule
Practical dosing and effect details

There are no controlled human trials of TB-500 itself (a thymosin beta-4 fragment), so the schedule in the table is compiled from community protocols and documented use rather than randomized trials.

The logic is straightforward: a loading phase (4–5 mg weekly, split into 2 injections over 4–6 weeks) sets a higher administration frequency at the start, after which the maintenance dose (2–2.5 mg) steps down first to weekly and then to every other week. In practice, the weekly total during maintenance is roughly half the loading-phase weekly total, and spaced maintenance halves it again while keeping the same single dose.

This shift from frequent to less frequent administration is typical of peptide protocols, where the goal is to first reach a stable level of exposure and then sustain it with fewer injections. These figures are a generalized reference to regimens described in the literature and community sources, not a clinical recommendation and not instructions for self-administration.

Frequently asked questions

What is the weekly TB-500 dose? During loading, 4–5 mg per week split into 2 injections; during maintenance, 2–2.5 mg once weekly, and in the spaced regime the same single dose every other week.

How long is a TB-500 course? Community protocols run 4–6 weeks of loading followed by 4–6 weeks of maintenance. No longer controlled schedules exist, because the fragment has never been through human clinical trials.

How many U-100 syringe units is a dose? It depends on the concentration of the reconstituted vial: units = dose (mg) divided by concentration (mg/mL) times 100. For example, with a 5 mg vial in 2 mL (2.5 mg/mL), a 2.5 mg dose is 1 mL, i.e. 100 units.

What are the side effects of TB-500? There is no established side-effect profile: no controlled human studies of TB-500 exist, so safety data are limited to individual reports rather than systematic observation.

How to reconstitute

An example reconstitution for convenient dosing. The exact ratios depend on your vial. For research reference only — not medical guidance.

  1. 1Add the diluentUse bacteriostatic water. Example: 2 ml into a 5 mg vial.TB-5005 mg+ 2 mlDiluent
  2. 2Get the concentrationExample: 5 mg in 2 ml =TB-5002.5 mg/ml(2,500 mcg/ml)
  3. 3Work out the volume per doseFor example, for a 2.5 mg dose:2.5 mg = 1 ml= 100 u. (U-100)

This is only an example calculation. You can use a different diluent volume — plug your own numbers into the calculator. Open calculator →

Research protocols

TB-500: reference regimens

Controlled data on this compound are limited.

TB-500 (a thymosin beta-4 fragment) is reconstituted from lyophilized powder and given subcutaneously.

TB-500 is positioned as a thymosin beta-4 fragment.

More scientific background in the TB-500 monograph

Notes and safety

  • • TB-500 is a research peptide. Human safety and efficacy data are limited.
  • • The regimens shown are based on publications and research protocols, not clinical recommendations.
  • • Individual reactions may vary. Published protocols typically start dosing at the lower end of the reported range.
  • • Not recommended for use with chronic illness, pregnancy, or breastfeeding.
  • • This information is for educational purposes and is not medical advice.
This is not medical advice — research information only.This material is not intended for diagnosis, treatment or prevention of disease.